Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Pati… (NCT03640273) | Clinical Trial Compass
CompletedPhase 2
Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients
Thailand72 participantsStarted 2017-11-23
Plain-language summary
1. To compare the effectiveness of Prapchompoothaweep crude drug at 3,000 mg per day and Loratadine 10 mg per day for treatment in Allergic Rhinitis patients. (Clinical Trial Phase II)
2. To evaluate the safety and adverse effect of Prapchompoothaweep crude drug at 3,000 mg and Loratadine 10 mg for Allergic Rhinitis patients.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged between 18-70 years old.
* Patients with history of allergic rhinitis based on ARIA guidelines. (itching and nasal obstruction, watery nasal discharge, sneezing ,congestion)
* Patients with moderate allergic rhinitis was diagnosed by physicians.
* Have no nasal septum perforation, nasal polyp or sinus surgery.
* Have no serious medical conditions: Heart disease, Liver disease, Renal disease, Hypertension, Peptic Ulcer and Gastroesophageal reflux disease (GERD), severe Asthma, Tuberculosis.
* Have normal range of Hematology test for Liver and Renal function.
* No Pregnant or Lactation.
* Do not taking a medicine constantly.
* Volunteers are willing to participate this study.
Exclusion Criteria:
* Allergic reactions to Prapchompoothaweep remedy and Loratadine.
* Allergic reaction to dairy products.
* Have severe urticaria and anaphylaxis.
* Have a serious condition of immunodeficiency disease: HIV in the previous month before being recruited in the study.
* Participate in another study.